Researchers at the University of Southampton will investigate whether weight loss and diabetes medications such as Ozempic could help boost the effectiveness of immunotherapy.

They are undertaking a new research project to better understand why breast cancer is less responsive to treatment and more likely to spread in women with obesity.

Read the full article here.